UPDATE: Exponent, Inc. (EXPO) Tops Q2 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mailGet Alerts EXPO Hot Sheet
Price: $73.15 +0.83%
EPS Growth %: +9.1%
Financial Fact:
Reimbursements: 3.45M
Today's EPS Names:
FNLC, LSBK, OVLY, More
EPS Growth %: +9.1%
Financial Fact:
Reimbursements: 3.45M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
(Updated - July 18, 2017 4:09 PM EDT)
(updated to add guidance outlook)
Exponent, Inc. (NASDAQ: EXPO) reported Q2 EPS of $0.51, $0.10 better than the analyst estimate of $0.41. Revenue for the quarter came in at $87.84 million versus the consensus estimate of $81.21 million.
Guidance:
Expects FY 2017 sales to grow mid-to-high single digits.
For earnings history and earnings-related data on Exponent, Inc. (EXPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Integra LifeSciences (IART) Tops Q3 EPS by 3c; offers guidance
- Medpace Holdings (MEDP) Tops Q3 EPS by 40c; offers guidance
- CNB Financial (CCNE) Misses Q3 EPS by 6c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
